Dr. Monty Pal introduces the program by outlining the evolving treatment landscape for advanced renal cell carcinoma (RCC) ...

Researchers at Peter MacCallum Cancer Centre have developed a digital phenotype to assist with automatically identifying ...

Dr. Monty Pal discusses the historical role of the International Metastatic Renal Cell Database Consortium (IMDC) risk ...

A review from five studies has found no added benefit of using Daiichi Sankyo’s Radicava (edaravone) and Sanofi’s Rilutek ...

The trial of Fintepla in Dravet Syndrome and LGS was run by researchers at the Brno Epilepsy Centre in Czechia.

More physicians are discussing hormone replacement therapy with breast cancer survivors when menopause hits.

Algorithms are opaque, they optimise for the wrong things — engagement, virality, outrage — and they’re not neutral ...

Anchor Point Tracking, designed for use with the new RefleXion X2 platform, underpins SCINTIX therapy with higher fidelity biologic data.

Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans to release its second quarter 2026 financial results ...

Senator Warren's June 24 push to overhaul merger review for AI deals puts a regulatory cloud over acquihire structures that Big Tech has spent $40 billion perfecting, and it arrives with at least some ...

Spread the love“`html Nausea is an uncomfortable sensation that many people experience at some point in their lives. It can stem from various factors, including motion sickness, medication side ...

A large analysis suggests that a multivariable risk assessment tool, called Stockholm3, can detect substantially more ...